EXSCIENTIA DRIVEN BY KNOWLEDGE
LIVE

Serial Number

79340816

Owner

Exscientia AI Limited

Attorney

David Johnson

Filing Date

Mar 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

EXSCIENTIA DRIVEN BY KNOWLEDGE Trademark

Serial Number: 79340816 • Registration: 7265239

EXSCIENTIA DRIVEN BY KNOWLEDGE is a trademark filed by Exscientia AI Limited on March 14, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Exscientia AI Limited (8 trademarks)

Level 3, Dundee One River Court,

Entity Type: 99

Trademark Details

Filing Date

March 14, 2022

Registration Date

January 9, 2024

Published for Opposition

October 24, 2023

Goods & Services

Downloadable computer software for analysis and interpretation of biological data using the combination of biology, computer science, information engineering, mathematics and statistics; Downloadable computer software for computer assisted molecule design; Downloadable computer software for chemical and biological research and analysis; Downloadable computer software for pharmaceutical research and development services; Downloadable computer software for diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for scientific research purposes for use in the field of molecular research and to combat disease; downloadable computer software for use in the research and development of pharmaceutical products; downloadable computer software for cell analysis; downloadable computer software for the use in managing scientific projects; downloadable computer software for the design of chemical structures; downloadable computer software for the analysis of biological or chemical activity; downloadable artificial intelligence software for healthcare, pharmaceuticals and diagnostics

Pharmaceutical preparations for the treatment of pain, viral diseases, namely, coronavirus, herpes, and hepatitis, cancer, lung cancer, pancreatic cancer, haematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, and neurological cancer, mental and physical disorders and conditions, namely, schizophrenia, mental health disorders, eating disorders and addictions, and nicotine addiction, skin conditions, namely, dermatitis, skin pigmentation diseases, psoriasis, and eczema, respiratory infections, eye infections, bacterial and parasitic infections, namely, malaria and tuberculosis, respiratory conditions, anxiety, arthritis, neurological diseases, namely, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, immunologic diseases and disorders, namely Alzheimer's, Parkinson's disease, ulcerative colitis, multiples sclerosis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), and chronic obstructive pulmonary diseases (COPD), musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, peripheral nervous system (PNS) diseases, and cardiovascular diseases and disorders; Medical preparations for the treatment of pain, viral diseases, namely, coronavirus, herpes, and hepatitis, cancer, lung cancer, pancreatic cancer, haematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, and neurological cancer, mental and physical disorders and conditions, namely, schizophrenia, mental health disorders, eating disorders and addictions, and nicotine addiction, skin conditions, namely, dermatitis, skin pigmentation diseases, psoriasis, and eczema, respiratory infections, eye infections, bacterial and parasitic infections, namely, malaria and tuberculosis, respiratory conditions, anxiety, arthritis, neurological diseases, namely, Huntington's disease, cerebral palsy, brain injury, spinal cord injury, and seizure disorders, immunologic diseases and disorders, namely Alzheimer's, Parkinson's disease, ulcerative colitis, multiples sclerosis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), and chronic obstructive pulmonary diseases (COPD), musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, peripheral nervous system (PNS) diseases, and cardiovascular diseases and disorders; Veterinary preparations for the treatment of pain, viral diseases, namely, paramyxovirus, influenza A virus, coronavirus, herpes, and hepatitis, wounds, cancer, lung cancer, pancreatic cancer, haematological cancer, colorectal cancer, breast cancer, bladder cancer, cervical cancer, gynecologic cancer, head and neck cancer, kidney cancer, liver cancer, myeloma, ovarian cancer, prostate cancer, skin cancer, thyroid cancer, uterine cancer, and neurological cancer, mental and physical disorders and conditions, namely, mental health disorders, musculoskeletal diseases, bone diseases, central nervous system (CNS) diseases, cardiovascular diseases and disorders, skin conditions, namely, dermatitis, skin pigmentation diseases, psoriasis, and eczema, respiratory infections, eye infections, bacterial and parasitic infections, namely, malaria and tuberculosis, respiratory conditions, arthritis, inflammatory diseases, namely, inflammatory bowel diseases, and inflammatory connective tissue diseases, immunologic diseases and disorders, namely Alzheimer's, ulcerative colitis, immuno-oncological diseases, atopic dermatitis, asthma, inflammatory bowel diseases (IBD), systemic lupus erythematosus (SLE), and chronic obstructive pulmonary diseases (COPD), allergies, and anxiety; veterinary preparations, namely, vaccines for animals, and sanitary substances for medical use for the treatment of autoimmune diseases, autoimmune diseases, specifically psoriasis, arthritis, and Crohn's disease; sanitary preparations for medical purposes; dietetic food adapted for medical or veterinary use, food for babies; dietetic substances in the nature of dietetic food adapted for medical or veterinary use; Dietary supplements for human beings and animals; plasters for medical purposes; materials for dressings, namely, gauze, bandages; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; pharmaceutical, veterinary and sanitary substances and preparations, namely, antifungals, antivirals, herbicides, antibiotics

Medical diagnostic testing and medical screening services

Scientific and technological services, namely, scientific research, analysis, testing in the field of research and development of pharmaceutical products and molecule design and services relating thereto; industrial analysis and industrial research services in the field of research and development of pharmaceutical products, molecule design and robotics for lab automation and industrial design services; quality control and authentication services in the field of works of scientific research for others; design and development of computer hardware and software; Bioinformatic services, namely, analysis and interpretation of biological data using the combination of biology, computer science, information engineering, mathematics and statistics for others; computer assisted molecule design; identification of biological targets, networks and pathways; chemical and biological research and analysis; pharmaceutical research and development services; diagnostic and screening services, namely, conducting diagnostic testing and evaluation of molecules developed through artificial intelligence means for scientific research purposes to combat diseases

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 25, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 13, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 13, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 13, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 13, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 13, 2025 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Jun 1, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 29, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 10, 2024 FICS
FINAL DISPOSITION PROCESSED
Apr 10, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 9, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 9, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 12, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 25, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 25, 2023 OPNR
NOTIFICATION PROCESSED BY IB
Oct 24, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 4, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 4, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 21, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 21, 2023 TROA
REFUSAL PROCESSED BY IB
Mar 15, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 22, 2023 RFCS
REFUSAL PROCESSED BY MPU
Feb 22, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 27, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 26, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 25, 2022 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 4, 2022 ADCH
APPLICATION FILING RECEIPT MAILED
May 24, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 20, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 19, 2022 REPR